Literature DB >> 24426368

Successful management of chronic refractory immune thrombocytopenia with laparoscopic splenectomy in a patient with acute promyelocytic leukemia.

Ahmet Emre Eskazan1, Ayse Salihoglu2, Emine Gulturk2, Seniz Ongoren Aydin2, Nukhet Tuzuner3, Yildiz Aydin2.   

Abstract

Acute promyelocytic leukemia (APL) is a particular type of acute myeloid leukemia with characteristic biological and clinical features, the frequent association at diagnosis of a severe hemorrhagic diathesis. Immune thrombocytopenia (ITP) is a common autoimmune disease characterized by low platelet counts and an increased risk of bleeding. Here we present a patient with the diagnosis of APL who achieved and maintained a remission with an induction consisting of idarubicin and ATRA, and then developed corticosteroid refractory ITP which is successfully treated with laparoscopic splenectomy.

Entities:  

Keywords:  APL; Acute promyelocytic leukemia; ITP; Immune thrombocytopenia; Splenectomy

Year:  2012        PMID: 24426368      PMCID: PMC3710553          DOI: 10.1007/s12288-012-0173-8

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  16 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

Authors:  James B Bussel; David J Kuter; James N George; Robert McMillan; Louis M Aledort; George T Conklin; Alan E Lichtin; Roger M Lyons; Jorge Nieva; Jeffrey S Wasser; Israel Wiznitzer; Reggie Kelly; Chien-Feng Chen; Janet L Nichol
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

Review 3.  Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.

Authors:  Donald M Arnold; Francesco Dentali; Mark A Crowther; Ralph M Meyer; Richard J Cook; Christopher Sigouin; Graeme A Fraser; Wendy Lim; John G Kelton
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

Review 4.  Drug-induced immune thrombocytopenia.

Authors:  Richard H Aster; Daniel W Bougie
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245

5.  Laparoscopic splenectomy for immune thrombocytopenia (ITP) patients with platelet counts lower than 1 × 109/L.

Authors:  Zhong Wu; Jin Zhou; Prasoon Pankaj; Bing Peng
Journal:  Int J Hematol       Date:  2011-11-05       Impact factor: 2.490

6.  Post-transfusion purpura: immunologic aspects and therapy.

Authors:  N Abramson; P D Eisenberg; R H Aster
Journal:  N Engl J Med       Date:  1974-11-28       Impact factor: 91.245

Review 7.  Acute promyelocytic leukemia: from genetics to treatment.

Authors:  F Grignani; M Fagioli; M Alcalay; L Longo; P P Pandolfi; E Donti; A Biondi; F Lo Coco; F Grignani; P G Pelicci
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

8.  A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

Authors:  M A Sanz; G Martín; C Rayón; J Esteve; M González; J Díaz-Mediavilla; P Bolufer; E Barragán; M J Terol; J D González; D Colomer; C Chillón; C Rivas; T Gómez; J M Ribera; R Bornstein; J Román; M J Calasanz; J Arias; C Alvarez; F Ramos; G Debén
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

9.  Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia.

Authors:  Satoshi Horino; Takeshi Rikiishi; Hidetaka Niizuma; Hiroshi Abe; Yuko Watanabe; Masaei Onuma; Yoshiyuki Hoshi; Yoji Sasahara; Miyako Yoshinari; Takuro Kazama; Yutaka Hayashi; Satoru Kumaki; Shigeru Tsuchiya
Journal:  Int J Hematol       Date:  2009-10-10       Impact factor: 2.490

Review 10.  Acute promyelocytic leukemia.

Authors:  R P Warrell; H de Thé; Z Y Wang; L Degos
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245

View more
  2 in total

Review 1.  Autoimmune Complications in Hematologic Neoplasms.

Authors:  Wilma Barcellini; Juri Alessandro Giannotta; Bruno Fattizzo
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

Review 2.  Immune Phenomena in Myeloid Neoplasms: An "Egg or Chicken" Question.

Authors:  Wilma Barcellini; Bruno Fattizzo
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.